GPT and Alzheimer disease: We investigated the association between serum-based liver function markers and AD diagnosis, cognition, and AD pathophysiological characteristics based on the A/T/N framework for AD biomarkers in the ADNI cohort.39 Our findings suggest that the decreased levels of ALT and elevated AST to ALT ratio that were observed in patients with AD were associated with poor cognition and reduced brain glucose metabolism.